Clinical efficacy of advanced esophageal cancer treated with esophageal stent placement by endoscopic distance measurement and blind push insertion(182 cases)
- VernacularTitle:内镜测距盲推置入覆膜食管支架治疗晚期食管癌的临床疗效(附182例报告)
- Author:
Hongqing QIU
1
;
Danhua ZHOU
1
;
Yaping LU
1
Author Information
- Publication Type:Journal Article
- Keywords: ultra-slim esophagogastroduodenoscope; endoscopic distance measurement; blind insertion method; advanced esophageal cancer; stent
- From: China Journal of Endoscopy 2025;31(7):86-90
- CountryChina
- Language:Chinese
- Abstract: Objective To investigate the clinical efficacy of placing a covered esophageal stent by blind pushing method under endoscopic distance measurement in the treatment of advanced esophageal cancer.Method Clinical data of 182 patients with advanced esophageal cancer who were treated by the above method from January 2014 to December 2023 were retrospectively analyzed,and the situations of operation time,patient comfort,accuracy of stent placement,postoperative bleeding,and postoperative chest pain were observed.Result All 182 patients with advanced esophageal cancer were successfully implanted with the covered esophageal stent by the blind pushing method under endoscopic distance measurement.The average placement time was(11.0±4.0)min,and the position of the stent was within 0.5 cm of the expected position.The patients could eat semi-liquid food within 6 h after the operation.No obvious symptoms such as nausea,vomiting and choking cough occurred during the implantation process.Postoperative bleeding was observed in 25 patients(13.7%).No intravenous anesthesia was required,no perforation occurred after the operation,the incidence of postoperative chest pain was documented at 82.4%.The dysphagia problem of the patients was significantly alleviated.Conclusion The endoscopic distance measurement and blind push insertion demonstrate advantages of procedural simplicity,accurate positioning,reducing procedure-related complications,and minimal patient discomfort in patients with advanced esophageal carcinoma and obstruction,establishing its clinical applicability as a novel approach for esophageal stent placement.
